Physician profile
Hunter Scheib
NPI 1518602705
$3,984.54
in general payments reported to CMS, 2019-2025
22 companies · $1,548 in 2025
The $1,548 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $85.81 · 2023: $723 · 2024: $1,627 · 2025: $1,548.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,343 · Travel and Lodging: $556.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,343.05 |
| Travel and Lodging | $555.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,113.94 | 2022-2025 | Ams 700 Cxr Rte Kit, Ams 700, Spaceoar System |
| Sumitomo Pharma America, INC. | $1,113.69 | 2023-2025 | Gemtesa, Orgovyx |
| Teleflex LLC | $420.63 | 2024-2025 | Barrigel, Urolift |
| Abbvie INC. | $179.66 | 2023-2025 | |
| Axonics, INC. | $160.41 | 2024 | Bulkamid, Axonics |
| Stryker Corporation | $160.08 | 2025 | 1788 |
| Endo USA, INC. | $149.01 | 2024-2025 | Xiaflex |
| Procept Biorobotics Corporation | $97.79 | 2024 | Aquabeam System |
| Endo Pharmaceuticals INC. | $82.58 | 2023-2024 | Xiaflex, Aveed |
| Pfizer INC. | $74.41 | 2025 | |
| Myriad Genetic Laboratories, INC. | $62.87 | 2022-2024 | Prolaris, Myrisk |
| Urogen Pharma, INC. | $54.38 | 2024-2025 | |
| Coloplast Corp | $51.40 | 2023-2024 | Titan |
| Vertex Pharmaceuticals Incorporated | $51.19 | 2024-2025 | |
| Olympus America INC. | $37.04 | 2025 | Itind System |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $34.35 | 2023 | Seglentis |
| Laborie Medical Technologies Corp. | $33.55 | 2024-2025 | |
| Accord Healthcare, INC. | $31.06 | 2024-2025 | |
| 180 Medical, INC. | $23.51 | 2022 | |
| Medtronic, INC. | $21.39 | 2023 | Interstim |
| Myovant Sciences INC. | $17.58 | 2022 | |
| Dendreon Pharmaceuticals LLC | $14.02 | 2025 | Provenge |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hunter Scheib listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.